The progression of cardiometabolic disease: Validation of a new cardiometabolic disease staging system applicable to obesity

AACE Comprehensive Diabetes Management Algorithm 2013

(2015) Alan Garber et al.   Endocrine Practice

Economic Costs of Diabetes in the U.S. in 2012

(2013)   DIABETES CARE

Diagnosis and Management of Prediabetes in the Continuum of Hyperglycemia—When do the Risks of Diabetes Begin? A Consensus Statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists

(2013) Alan Garber et al.   Endocrine Practice

Clinical Practice Guidelines for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patient—2013 Update: Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery

(2013) Jeffrey Mechanick et al.   Endocrine Practice

Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management

(2013) William Timothy Garvey   Expert Opinion On Drug Safety

Are there still healthy obese patients?

(2013) Matthias Blüher   Current Opinion in Endocrinology Diabetes and Obesity

Long-Term Outcomes After Bariatric Surgery

(2012) Paul E. OʼBrien et al.   ANNALS OF SURGERY

Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010

(2012) Katherine M. Flegal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

(2011) W Timothy Garvey et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity

(2011) R. S. Padwal et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

(2011) Goodarz Danaei et al.   LANCET

Incident Cardiovascular Disease Events in Metabolically Benign Obese Individuals

(2011) Alexandra D. Ogorodnikova et al.   Obesity

Intramyocellular Lipid and Insulin Resistance: Differential Relationships in European and African Americans

(2011) Katherine H. Ingram et al.   Obesity

Comparison of Accuracy of Diabetes Risk Score and Components of the Metabolic Syndrome in Assessing Risk of Incident Type 2 Diabetes in Inter99 Cohort

(2011) Tracy B. Shafizadeh et al.   PLoS One

Performance of A1C for the Classification and Prediction of Diabetes

(2010) E. Selvin et al.   DIABETES CARE

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

(2010) Steven R. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

(2009)   LANCET

The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering

(2008) Rachel P. Wildman   ARCHIVES OF INTERNAL MEDICINE

General Cardiovascular Risk Profile for Use in Primary Care

(2008) Ralph B. D’Agostino et al.   CIRCULATION